Cargando…

Inpatient care of neuromyelitis optica spectrum disorder in Germany: Nationwide analysis from 2010 to 2021

BACKGROUND: Despite tremendous development in the treatment of neuromyelitis optica spectrum disorder (NMOSD), less is known about the characteristics of hospitalized patients and inpatient care utilization. OBJECTIVE: To investigate the development of inpatient NMOSD case numbers and implemented im...

Descripción completa

Detalles Bibliográficos
Autores principales:	Richter, Daniel, Bartig, Dirk, Tönges, Lars, Kümpfel, Tania, Schwake, Carolin, Gold, Ralf, Krogias, Christos, Ayzenberg, Ilya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331198/ https://www.ncbi.nlm.nih.gov/pubmed/37435571 http://dx.doi.org/10.1177/20552173231184433

Ejemplares similares

The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany
por: Richter, Daniel, et al.
Publicado: (2021)

Multiple sclerosis is not associated with an increased risk for severe COVID-19: a nationwide retrospective cross-sectional study from Germany
por: Richter, Daniel, et al.
Publicado: (2021)

Clinical Profiles and Mortality of COVID‐19 Inpatients with Parkinson's Disease in Germany
por: Scherbaum, Raphael, et al.
Publicado: (2021)

Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany
por: Richter, Daniel, et al.
Publicado: (2021)

Letter to the editor: risk comorbidities of COVID-19 in Parkinson’s disease patients in Germany
por: Richter, Daniel, et al.
Publicado: (2020)

Hospital Admissions for Neurodegenerative Diseases during the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany
por: Scherbaum, Raphael, et al.
Publicado: (2021)

Hospitalization Rates and Comorbidities in Patients with Progressive Supranuclear Palsy in Germany from 2010 to 2017
por: Zella, Maria Angela Samis, et al.
Publicado: (2020)

COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany
por: Scherbaum, Raphael, et al.
Publicado: (2022)

Dynamics of Parkinson’s Disease Multimodal Complex Treatment in Germany from 2010–2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers
por: Richter, Daniel, et al.
Publicado: (2019)

Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)
por: Trebst, Corinna, et al.
Publicado: (2013)

Inpatient TIA and stroke care in adult patients in Germany - retrospective analysis of nationwide administrative data sets of 2011 to 2017
por: Eyding, Jens, et al.
Publicado: (2019)

Distribution and evolution of acute interventional ischemic stroke treatment in Germany from 2010 to 2016
por: Weber, Ralph, et al.
Publicado: (2019)

Tryptophan immunoadsorption during pregnancy and breastfeeding in patients with acute relapse of multiple sclerosis and neuromyelitis optica
por: Hoffmann, Frank, et al.
Publicado: (2018)

Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)
por: Hümmert, Martin W, et al.
Publicado: (2023)

Update on the diagnosis and treatment of neuromyelits optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part I: Diagnosis and differential diagnosis
por: Jarius, Sven, et al.
Publicado: (2023)

Neuromyelitis Optica
por: Misra, M. C., et al.
Publicado: (1953)

Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014)

Letter to the Editor: Analysis of stroke patient migration for mechanical thrombectomy and changes in neurointerventional center size in Germany
por: Weber, Ralph, et al.
Publicado: (2021)

Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody–Seropositive Patients
por: Ayzenberg, Ilya, et al.
Publicado: (2021)

Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75
por: Krumbholz, Markus, et al.
Publicado: (2015)

The history of neuromyelitis optica
por: Jarius, Sven, et al.
Publicado: (2013)

Neuromyelitis optica and neuroregeneration
Publicado: (2012)

Immunotherapy of Neuromyelitis Optica
por: Bienia, Benjamin, et al.
Publicado: (2013)

Acute ischemic stroke care in Germany – further progress from 2016 to 2019
por: Richter, Daniel, et al.
Publicado: (2021)

A full year of the COVID‐19 pandemic with two infection waves and its impact on ischemic stroke patient care in Germany
por: Richter, Daniel, et al.
Publicado: (2021)

Comprehensive review of neuromyelitis optica and clinical characteristics of neuromyelitis optica patients in Puerto Rico
por: Zarei, Sara, et al.
Publicado: (2018)

Ovarian Reserve in Women With Neuromyelitis Optica Spectrum Disorder
por: Thöne, Jan, et al.
Publicado: (2018)

Disease exacerbation after rituximab induction in neuromyelitis optica
por: Perumal, Jai S., et al.
Publicado: (2015)

New Insights into Neuromyelitis Optica
por: Kim, Woojun, et al.
Publicado: (2011)

Experimental Models of Neuromyelitis Optica
por: Bradl, Monika, et al.
Publicado: (2013)

Molecular Pathogenesis of Neuromyelitis Optica
por: Bukhari, Wajih, et al.
Publicado: (2012)

B lymphocytes in neuromyelitis optica
por: Bennett, Jeffrey L., et al.
Publicado: (2015)

Update on biomarkers in neuromyelitis optica
por: Melamed, Esther, et al.
Publicado: (2015)

Multisystem involvement in neuromyelitis optica
por: Langille, Megan M., et al.
Publicado: (2015)

A Case of Neuromyelitis Optica
por: DE, M. N., et al.
Publicado: (1946)

A Case of Neuromyelitis Optica
por: Shone, S.
Publicado: (1940)

The Gut Microbiome in Neuromyelitis Optica
por: Zamvil, Scott S., et al.
Publicado: (2017)

Treatment strategies for neuromyelitis optica
por: Huang, Tzu-Lun, et al.
Publicado: (2018)

Cognitive Impairment in Neuromyelitis Optica
por: YABALAK, Ahmet, et al.
Publicado: (2020)

Educational Case: Neuromyelitis optica
por: Kitchens, Nathaniel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_74agliu1i0j3tlos7lav6d93tv